# Myrlene Sanon

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/myrlene-sanon/

## Facts

| Field | Value |
| --- | --- |
| Citations | 327 |
| Field | Inflammatory Bowel Disease |
| h-index | 10 |
| i10-index | 10 |
| Last Known Institution | Johnson & Johnson (United States) |
| OpenAlex ID | https://openalex.org/A5112428070 |
| Works | 53 |

## Researcher papers

- [Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review](https://scholariq.org/papers/economic-and-quality-of-life-burden-of-anemia-on-patients-with-ckd-on-dialysis-a/)
- [Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With Dementia](https://scholariq.org/papers/association-of-the-us-food-and-drug-administration-antipsychotic-drug-boxed/)
- [Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review](https://scholariq.org/papers/economic-burden-and-health-related-quality-of-life-associated-with-current/)
- [Incorporating Calibrated Model Parameters into Sensitivity Analyses](https://scholariq.org/papers/incorporating-calibrated-model-parameters-into-sensitivity-analyses/)
- [The impact of parenteral nutrition preparation on bloodstream infection risk and costs](https://scholariq.org/papers/the-impact-of-parenteral-nutrition-preparation-on-bloodstream-infection-risk-and/)
- [Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States](https://scholariq.org/papers/cost-effectiveness-of-3-years-of-adjuvant-imatinib-in-gastrointestinal-stromal/)
- [A Retrospective, Observational Study of Patient Outcomes for Critically Ill Patients Receiving Parenteral Nutrition](https://scholariq.org/papers/a-retrospective-observational-study-of-patient-outcomes-for-critically-ill/)
- [Epidemiology, survival, and costs of localized gastrointestinal stromal tumors](https://scholariq.org/papers/epidemiology-survival-and-costs-of-localized-gastrointestinal-stromal-tumors/)
- [The conceptual relevance of assessment measures in patients with mild/mild‐moderate Alzheimer's disease](https://scholariq.org/papers/the-conceptual-relevance-of-assessment-measures-in-patients-with-mild-mild/)
- [Effect of Anemia on Physical Function and Physical Activity in CKD: The National Health and Nutrition Examination Survey, 1999–2016](https://scholariq.org/papers/effect-of-anemia-on-physical-function-and-physical-activity-in-ckd-the-national/)
- [Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage](https://scholariq.org/papers/excess-healthcare-costs-in-patients-with-autosomal-dominant-polycystic-kidney/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)

## Researcher university

- [Johnson & Johnson (United States)](https://scholariq.org/institutions/johnson-and-johnson-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.